{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:52:10Z","timestamp":1790707930840,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T00:00:00Z","timestamp":1470614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T00:00:00Z","timestamp":1470614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fibroblast growth factor 21 (FGF21) is a hepatokine that regulates glucose and lipid metabolism in the liver. We sought to determine the role of FGF21 in hepatic steatosis in mice exposed to chronic alcohol treatment and to discern underlying mechanisms. Male FGF21 knockout (FGF21 KO) and control (WT) mice were divided into groups that were fed either the Lieber DeCarli diet containing 5% alcohol or an isocaloric (control) diet for 4 weeks. One group of WT mice exposed to alcohol received recombinant human FGF21 (rhFGF21) in the last 5 days. Liver steatosis and inflammation were assessed. Primary mouse hepatocytes and AML-12 cells were incubated with metformin or rhFGF21. Hepatic genes and the products involved in <jats:italic>in situ<\/jats:italic> lipogenesis and fatty acid \u03b2-oxidation were analyzed. Alcohol exposure increased circulating levels and hepatic expression of FGF21. FGF21 depletion exacerbated alcohol-induced hepatic steatosis and liver injury, which was associated with increased activation of genes involved in lipogenesis mediated by SREBP1c and decreased expression of genes involved in fatty acid \u03b2-oxidation mediated by PGC1\u03b1. rhFGF21 administration reduced alcohol-induced hepatic steatosis and inflammation in WT mice. These results reveal that alcohol-induced FGF21 expression is a hepatic adaptive response to lipid dysregulation. Targeting FGF21 signaling could be a novel treatment approach for alcoholic steatohepatitis.<\/jats:p>","DOI":"10.1038\/srep31026","type":"journal-article","created":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T09:22:42Z","timestamp":1470648162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury"],"prefix":"10.1038","volume":"6","author":[{"given":"Yanlong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guicheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Man","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moosa","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"McClain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenke","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,8]]},"reference":[{"key":"BFsrep31026_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nature07202","volume":"454","author":"SJ Bensinger","year":"2008","unstructured":"Bensinger, S. J. & Tontonoz, P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454, 470\u2013477 (2008).","journal-title":"Nature"},{"key":"BFsrep31026_CR2","doi-asserted-by":"publisher","first-page":"29342","DOI":"10.1074\/jbc.M202411200","volume":"277","author":"M You","year":"2002","unstructured":"You, M., Fischer, M., Deeg, M. A. & Crabb, D. W. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). The Journal of biological chemistry 277, 29342\u201329347 (2002).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep31026_CR3","doi-asserted-by":"publisher","first-page":"539-+","DOI":"10.1053\/j.gastro.2013.10.059","volume":"146","author":"Y Li","year":"2014","unstructured":"Li, Y. et al. Hepatic SIRT1 Attenuates Hepatic Steatosis and Controls Energy Balance in Mice by Inducing Fibroblast Growth Factor 21. Gastroenterology 146, 539-+ (2014).","journal-title":"Gastroenterology"},{"key":"BFsrep31026_CR4","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1053\/j.gastro.2004.09.049","volume":"127","author":"M You","year":"2004","unstructured":"You, M., Matsumoto, M., Pacold, C. M., Cho, W. K. & Crabb, D. W. The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology 127, 1798\u20131808 (2004).","journal-title":"Gastroenterology"},{"key":"BFsrep31026_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jhep.2012.08.018","volume":"58","author":"TM Leung","year":"2013","unstructured":"Leung, T. M. & Nieto, N. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. Journal of hepatology 58, 395\u2013398 (2013).","journal-title":"Journal of hepatology"},{"key":"BFsrep31026_CR6","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","volume":"115","author":"A Kharitonenkov","year":"2005","unstructured":"Kharitonenkov, A. et al. FGF-21 as a novel metabolic regulator. The Journal of clinical investigation 115, 1627\u20131635 (2005).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep31026_CR7","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1210\/me.2010-0142","volume":"24","author":"K Fon Tacer","year":"2010","unstructured":"Fon Tacer, K. et al. Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse. Molecular Endocrinology 24, 2050\u20132064 (2010).","journal-title":"Molecular Endocrinology"},{"key":"BFsrep31026_CR8","doi-asserted-by":"crossref","unstructured":"Tanaka, N. et al. Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet. Biochimica et biophysica acta (2015).","DOI":"10.1016\/j.bbadis.2015.02.012"},{"key":"BFsrep31026_CR9","doi-asserted-by":"crossref","unstructured":"Talukdar, S. et al. FGF21 Regulates Sweet and Alcohol Preference. Cell Metab (2015).","DOI":"10.1016\/j.cmet.2015.12.008"},{"key":"BFsrep31026_CR10","doi-asserted-by":"publisher","first-page":"G892","DOI":"10.1152\/ajpgi.00575.2007","volume":"294","author":"M You","year":"2008","unstructured":"You, M., Liang, X., Ajmo, J. M. & Ness, G. C. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. American journal of physiology. Gastrointestinal and liver physiology 294, G892\u2013G898 (2008).","journal-title":"American journal of physiology. Gastrointestinal and liver physiology"},{"key":"BFsrep31026_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1053\/j.gastro.2013.11.008","volume":"146","author":"H Yin","year":"2014","unstructured":"Yin, H. et al. Deletion of SIRT1 From Hepatocytes in Mice Disrupts Lipin-1 Signaling and Aggravates Alcoholic Fatty Liver. Gastroenterology 146, 801\u2013811 (2014).","journal-title":"Gastroenterology"},{"key":"BFsrep31026_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1677\/JOE-09-0345","volume":"205","author":"PW Caton","year":"2010","unstructured":"Caton, P. W. et al. Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5. J Endocrinol 205, 97\u2013106 (2010).","journal-title":"J Endocrinol"},{"key":"BFsrep31026_CR13","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S1097-2765(01)00390-2","volume":"8","author":"P Puigserver","year":"2001","unstructured":"Puigserver, P. et al. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Molecular cell 8, 971\u2013982 (2001).","journal-title":"Molecular cell"},{"key":"BFsrep31026_CR14","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1016\/j.ajpath.2011.08.039","volume":"179","author":"Y Wang","year":"2011","unstructured":"Wang, Y. et al. Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. The American journal of pathology 179, 2866\u20132875 (2011).","journal-title":"The American journal of pathology"},{"key":"BFsrep31026_CR15","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.jnutbio.2013.02.001","volume":"24","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Lactobacillus rhamnosus GG reduces hepatic TNFalpha production and inflammation in chronic alcohol-induced liver injury. The Journal of nutritional biochemistry 24, 1609\u20131615 (2013).","journal-title":"The Journal of nutritional biochemistry"},{"key":"BFsrep31026_CR16","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.2337\/db07-1476","volume":"57","author":"X Zhang","year":"2008","unstructured":"Zhang, X. et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 57, 1246\u20131253 (2008).","journal-title":"Diabetes"},{"key":"BFsrep31026_CR17","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jhep.2010.05.018","volume":"53","author":"H Li","year":"2010","unstructured":"Li, H. et al. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. Journal of hepatology 53, 934\u2013940 (2010).","journal-title":"Journal of hepatology"},{"key":"BFsrep31026_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","volume":"139","author":"J Dushay","year":"2010","unstructured":"Dushay, J. et al. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology 139, 456\u2013463 (2010).","journal-title":"Gastroenterology"},{"key":"BFsrep31026_CR19","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1210\/en.2011-1496","volume":"153","author":"KR Feingold","year":"2012","unstructured":"Feingold, K. R. et al. FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob\/ob mice from the toxicity of sepsis. Endocrinology 153, 2689\u20132700 (2012).","journal-title":"Endocrinology"},{"key":"BFsrep31026_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","volume":"5","author":"T Inagaki","year":"2007","unstructured":"Inagaki, T. et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell metabolism 5, 415\u2013425 (2007).","journal-title":"Cell metabolism"},{"key":"BFsrep31026_CR21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","volume":"148","author":"PaulA Dutchak","year":"2012","unstructured":"Dutchak, Paul A. et al. Fibroblast Growth Factor-21 Regulates PPAR\u03b3 Activity and the Antidiabetic Actions of Thiazolidinediones. Cell 148, 556\u2013567 (2012).","journal-title":"Cell"},{"key":"BFsrep31026_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3803\/EnM.2014.29.2.105","volume":"29","author":"KH Bae","year":"2014","unstructured":"Bae, K. H., Kim, J. G. & Park, K. G. Transcriptional regulation of fibroblast growth factor 21 expression. Endocrinology and metabolism 29, 105\u2013111 (2014).","journal-title":"Endocrinology and metabolism"},{"key":"BFsrep31026_CR23","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.biochi.2012.10.019","volume":"95","author":"FG Schaap","year":"2013","unstructured":"Schaap, F. G., Kremer, A. E., Lamers, W. H., Jansen, P. L. & Gaemers, I. C. Fibroblast growth factor 21 is induced by endoplasmic reticulum stress. Biochimie 95, 692\u2013699 (2013).","journal-title":"Biochimie"},{"key":"BFsrep31026_CR24","doi-asserted-by":"publisher","first-page":"479348","DOI":"10.1155\/2012\/479348","volume":"2012","author":"L Longato","year":"2012","unstructured":"Longato, L. et al. Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in human chronic alcohol-related liver disease. Oxidative medicine and cellular longevity 2012, 479348 (2012).","journal-title":"Oxidative medicine and cellular longevity"},{"key":"BFsrep31026_CR25","doi-asserted-by":"publisher","first-page":"207594","DOI":"10.1155\/2012\/207594","volume":"2012","author":"JJ Galligan","year":"2012","unstructured":"Galligan, J. J. et al. Oxidative Stress and the ER Stress Response in a Murine Model for Early-Stage Alcoholic Liver Disease. Journal of toxicology 2012, 207594 (2012).","journal-title":"Journal of toxicology"},{"key":"BFsrep31026_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jhep.2010.07.023","volume":"54","author":"L Magne","year":"2011","unstructured":"Magne, L. et al. ATF4 and the integrated stress response are induced by ethanol and cytochrome P450 2E1 in human hepatocytes. Journal of hepatology 54, 729\u2013737 (2011).","journal-title":"Journal of hepatology"},{"key":"BFsrep31026_CR27","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.2337\/db10-0193","volume":"59","author":"FM Fisher","year":"2010","unstructured":"Fisher, F. M. et al. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 59, 2781\u20132789 (2010).","journal-title":"Diabetes"},{"key":"BFsrep31026_CR28","doi-asserted-by":"publisher","first-page":"e69330","DOI":"10.1371\/journal.pone.0069330","volume":"8","author":"Y Murata","year":"2013","unstructured":"Murata, Y. et al. Fgf21 impairs adipocyte insulin sensitivity in mice fed a low-carbohydrate, high-fat ketogenic diet. PloS one 8, e69330 (2013).","journal-title":"PloS one"},{"key":"BFsrep31026_CR29","unstructured":"Ye, D. et al. FGF21 protects against acetaminophen-induced hepatotoxicity by Potentiating PGC-1alpha-mediated antioxidant capacity in mice. Hepatology (2014)."},{"key":"BFsrep31026_CR30","doi-asserted-by":"publisher","first-page":"E283","DOI":"10.1152\/ajpendo.00361.2014","volume":"308","author":"GJ Wilson","year":"2015","unstructured":"Wilson, G. J. et al. GCN2 is required to increase fibroblast growth factor 21 and maintain hepatic triglyceride homeostasis during asparaginase treatment. American journal of physiology. Endocrinology and metabolism 308, E283\u2013E293 (2015).","journal-title":"American journal of physiology. Endocrinology and metabolism"},{"key":"BFsrep31026_CR31","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.2337\/db08-1775","volume":"58","author":"K Mai","year":"2009","unstructured":"Mai, K. et al. Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21. Diabetes 58, 1532\u20131538 (2009).","journal-title":"Diabetes"},{"key":"BFsrep31026_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1152\/advan.00052.2006","volume":"30","author":"H Liang","year":"2006","unstructured":"Liang, H. & Ward, W. F. PGC-1alpha: a key regulator of energy metabolism. Advances in physiology education 30, 145\u2013151 (2006).","journal-title":"Advances in physiology education"},{"key":"BFsrep31026_CR33","doi-asserted-by":"publisher","first-page":"e6812","DOI":"10.1371\/journal.pone.0006812","volume":"4","author":"N Scaglia","year":"2009","unstructured":"Scaglia, N., Chisholm, J. W. & Igal, R. A. Inhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK. PloS one 4, e6812 (2009).","journal-title":"PloS one"},{"key":"BFsrep31026_CR34","doi-asserted-by":"publisher","first-page":"33959","DOI":"10.1074\/jbc.M110.122978","volume":"285","author":"B Ponugoti","year":"2010","unstructured":"Ponugoti, B. et al. SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. The Journal of biological chemistry 285, 33959\u201333970 (2010).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep31026_CR35","first-page":"88","volume":"4","author":"M You","year":"2015","unstructured":"You, M., Jogasuria, A., Taylor, C. & Wu, J. Sirtuin 1 signaling and alcoholic fatty liver disease. Hepatobiliary Surg Nutr 4, 88\u2013100 (2015).","journal-title":"Hepatobiliary Surg Nutr"},{"key":"BFsrep31026_CR36","doi-asserted-by":"publisher","first-page":"12553","DOI":"10.1073\/pnas.1006962107","volume":"107","author":"MD Chau","year":"2010","unstructured":"Chau, M. D., Gao, J., Yang, Q., Wu, Z. & Gromada, J. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway. Proceedings of the National Academy of Sciences of the United States of America 107, 12553\u201312558 (2010).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep31026_CR37","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/0006-291X(60)90077-2","volume":"3","author":"MG Horning","year":"1960","unstructured":"Horning, M. G., Williams, E. A., Maling, H. M. & Brodie, B. B. Depot fat as source of increased liver triglycerides after ethanol. Biochemical and biophysical research communications 3, 635\u2013640 (1960).","journal-title":"Biochemical and biophysical research communications"},{"key":"BFsrep31026_CR38","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1254\/jjp.31.931","volume":"31","author":"M Muramatsu","year":"1981","unstructured":"Muramatsu, M., Kuriyama, K., Yuki, T. & Ohkuma, S. Hepatic lipogenesis and mobilization of peripheral fats in the formation of alcoholic fatty liver. Japanese journal of pharmacology 31, 931\u2013940 (1981).","journal-title":"Japanese journal of pharmacology"},{"key":"BFsrep31026_CR39","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1194\/jlr.M058610","volume":"56","author":"C Zhao","year":"2015","unstructured":"Zhao, C. et al. FGF21 mediates alcohol-induced adipose tissue lipolysis by activation of systemic release of catecholamine in mice. Journal of lipid research 56, 1481\u20131491 (2015).","journal-title":"Journal of lipid research"},{"key":"BFsrep31026_CR40","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","volume":"18","author":"G Gaich","year":"2013","unstructured":"Gaich, G. et al. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell metabolism 18, 333\u2013340 (2013).","journal-title":"Cell metabolism"},{"key":"BFsrep31026_CR41","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1093\/abbs\/gmu097","volume":"46","author":"S Zhu","year":"2014","unstructured":"Zhu, S. et al. FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway. Acta Biochim Biophys Sin (Shanghai) 46, 1041\u20131048 (2014).","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"BFsrep31026_CR42","doi-asserted-by":"publisher","first-page":"10853","DOI":"10.1073\/pnas.0904187106","volume":"106","author":"MJ Potthoff","year":"2009","unstructured":"Potthoff, M. J. et al. FGF21 induces PGC-1\u03b1 and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proceedings of the National Academy of Sciences 106, 10853\u201310858 (2009).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"BFsrep31026_CR43","doi-asserted-by":"publisher","first-page":"G32","DOI":"10.1152\/ajpgi.00024.2012","volume":"303","author":"Y Wang","year":"2012","unstructured":"Wang, Y. et al. Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. American journal of physiology. Gastrointestinal and liver physiology 303, G32\u2013G41 (2012).","journal-title":"American journal of physiology. Gastrointestinal and liver physiology"},{"key":"BFsrep31026_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cmet.2008.05.006","volume":"8","author":"T Inagaki","year":"2008","unstructured":"Inagaki, T. et al. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell metabolism 8, 77\u201383 (2008).","journal-title":"Cell metabolism"},{"key":"BFsrep31026_CR45","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/toxsci\/kfn079","volume":"104","author":"WO Osburn","year":"2008","unstructured":"Osburn, W. O. et al. Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice. Toxicological sciences: an official journal of the Society of Toxicology 104, 218\u2013227 (2008).","journal-title":"Toxicological sciences: an official journal of the Society of Toxicology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep31026","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep31026.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep31026.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T21:24:08Z","timestamp":1672867448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep31026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,8]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,11,14]]}},"alternative-id":["BFsrep31026"],"URL":"https:\/\/doi.org\/10.1038\/srep31026","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,8]]},"assertion":[{"value":"5 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31026"}}